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ABSTRACT
The serological characterisation of Helicobacter
pylori strains has been questioned, e.g., when the
presence or absence of the cag pathogenicity
island (PAI) is determined. This study compared
CagA-reactive serum antibodies, assessed with
immunoblot, with cag PAI status, as determined
by PCR. CagA serology results were available for
101 individuals contributing 202 bacterial samples
for cag PAI PCR. There was a high degree of
correlation between the two methods (kappa
coefﬁcient, 0.82; 95% conﬁdence interval, 0.68–
0.97). Combined with suggested biological expla-
nations for the discrepancies, this ﬁnding sup-
ports the application of well-evaluated serological
assays in the assessment of the cag PAI status of
H. pylori infections in clinical and epidemiological
studies.
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Helicobacter pylori infection is associated with
peptic ulcer and gastric cancer, with the bacterial
cag pathogenicity island (PAI) being a virulence
factor associated with these conditions. The cag
PAI encodes a type IV secretion apparatus that
induces a vigorous host response and translocates
the PAI-encoded CagA protein into epithelial cells
[1]. In epidemiological and microbiological stud-
ies, H. pylori cag PAI status is frequently assessed
either by the immune response to the immuno-
dominant CagA or by detection of the cagA gene.
Available serological tools to characterise infecting
H. pylori strains have been questioned because of
inadequate sensitivity, speciﬁcity and congruence
[2–4]. The present study investigated the agree-
ment between the occurrence of CagA-reactive
antibodies, as assessed by immunoblot, and cag
PAI status, as determined by PCR.
Family members from an epidemiological
study were invited to contribute blood and
undergo gastroscopy, followed by culture of
H. pylori with standard methods from antrum
and corpus biopsy specimens [5]. The study
subjects were not patients, and hence clinical
symptoms were not monitored systematically.
The local ethics committee approved the study,
and the participants gave informed consent. In
39 families, 104 individuals contributed 208 bac-
terial isolates that were found by molecular typing
to correspond to 80 distinct strains [5].
The serological CagA response was assessed by
immunoblot (HelicoBlot 2.0; Genelabs Diagnos-
tics, Singapore). For each biopsy specimen, bac-
terial DNA was prepared from a pool of all
colonies on the culture plate, and the presence or
absence of the cag PAI was determined by two
PCRs, followed by agarose gel electrophoresis
and staining with ethidium bromide (Fig. 1). First,
a fragment within the cagA gene was ampliﬁed
with primers cagAsbraF 5¢-ATGATGGCGTGATG
TTTGT-3¢ and cagAsbraR 5¢-TTTTCAAGGTCG
CTTTTTGC-3¢ [6]. Second, an empty-site PCR was
performed with primers UpCagF 5¢-ACTTTCA
CGCCCTTTCCCTCC-3¢ and DownCagR 5¢-TTG
CATGCGTTATTATTTCAC-3¢, which ﬂanked the
40-kb cag PAI and yielded a product when the
PAI was absent [7]. For the statistical analyses, a
data set was created with independent observa-
tions, i.e., with each strain and individual being
represented only once, by randomisation of iso-
lates for which both serology and PCR results
were available. The correlation between the
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immunoblot and PCR assays was estimated with
the kappa coefﬁcient (SAS program v. 8.02; SAS
Inc., Cary, NC, USA). Sensitivity and speciﬁcity
were calculated with exact binomial 95% conﬁd-
ence intervals (CIs).
Of the 208 isolates, 202 were from individuals
with available immunoblot results, of whom 174
also had PCR results. Randomisation yielded 66
independent observations, for which the correla-
tion between the two assays had a kappa coefﬁcient
of 0.82 (95% CI 0.68–0.97) (Table 1). Disagreement
between serology and PCR results was present in
one direction only, namelyCagA+ serology and cag
PAI– PCR. This ﬁnding could reﬂect limited im-
munoblot speciﬁcity (0.78; 95% CI 0.56–0.93) or
limited PCR sensitivity (0.90; 95% CI 0.77–0.97)
(Table 1). In the complete collection of 174 isolates,
the same unidirectional disagreement was
observed for all PCR- and serology-discordant
isolates, with similar kappa, sensitivity and specif-
icity point estimates as shown in Table 1.
It is unlikely that the observed discrepancy
between the two methods resulted from a lack of
PCR sensitivity, as the empty-site PCR yielded
products of the expected size. The immunoblot
used has been reported to have a speciﬁcity of
80–90% in determining the CagA status of an
infection [2–4], although either bacterial cagA or
CagA status was used as the reference, and the
imperfections of these comparisons should be
considered. The discordance could result from
additional cag PAI+ clones that remained unsam-
pled in the stomach. An H. pylori infection usually
involves a single predominant strain, but strain
variants that differ in cag PAI status may be
relatively common [6–8]. Furthermore, CagA
seropositivity could reﬂect a lingering immune
response towards a CagA+ infection that has been
replaced by a CagA– infection [9,10].
In previous studies, individuals with cagA+ or
CagA+ strains but CagA– serology have been
described, corresponding to a sensitivity of
71–90% for the present immunoblot [2–4]. The
cagA gene is linked closely to expression of the
CagA protein [11], but mutation may render
the secretion apparatus non-functional, thereby
limiting exposure of CagA to the immune system.
For example, a recent study found partial dele-
tions in the cag PAI in ten of 66 isolates, but these
often left an intact cagA gene [6]. It has also
been proposed that a detectable CagA immune
response could be hampered by host factors and
CagA variability [2,8,12].
The anticipated result in the PCR assay was an
ampliﬁed product in one reaction, with a negative
result in the other (Fig. 1). Of the 208 isolates, 28
from individuals with CagA+ immunoblots gave
ambiguous PCR results, with ampliﬁcation in
both or neither of the reactions. Twenty-four
isolates from 15 individuals yielded bands in both
PCRs, suggesting that these samples contained a
mixture of clones with and without the cag PAI
[6–8]. Four isolates, from two individuals, yielded
Fig. 1. cag PAI PCR and immunoblot results for a cag PAI+
strain and a cag PAI– strain. (a) PCR assay results for a cag
PAI+ strain (lanes 2 and 3) and a cag PAI– strain (lanes 4
and 5). Results of the cagA gene PCR are shown in lanes 2
and 4, and those of the empty-site PCR in lanes 3 and 5.
Lane 1 contains Molecular Weight Marker VI (Roche
Applied Sciences, Basel, Switzerland). (b) The immunoblot
results for the same individuals from whom the strains
were obtained: CagA+ (lane 1) and CagA– (lane 2).




Serology (with PCR as standard) PCR (with serology as standard)
cag PAI– cag PAI+ Sensitivity Speciﬁcity Sensitivity Speciﬁcity
CagA– 18 0 0.82 (0.68–0.97) 1.00 (0.92–1.00) 0.78 (0.56–0.93) 0.90 (0.77–0.97) 1.00 (0.81–1.00)
CagA+ 5 43
95% conﬁdence intervals are given in parentheses.
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no PCR products in either reaction, indicating that
the target sequences of the cagA primers were
mutated or deleted. The 28 isolates with ambigu-
ous PCR results were excluded from the evalua-
tion in Table 1. However, if they were included
and regarded as cag PAI+, in accordance with the
interpretations made above, the kappa coefﬁcient
was estimated as 0.80 (95% CI 0.64–0.95), com-
pared with 0.57 (95% CI 0.40–0.75) if they were
regarded as cag PAI–. The former value is essen-
tially identical to that in Table 1, thereby sup-
porting the original interpretations. The
occurrence of such PCR ambiguities could be
reduced by examining single-colony isolates, but
this increases the risk of overlooking strain
variants unless numerous colonies are included.
In conclusion, agreement between the results of
tests to determine the serological CagA status and
the cag PAI PCR results of H. pylori infections is
satisfactory, considering the biological prerequi-
sites. Genotypic approaches are required when
the characteristics of individual bacterial clones
are being studied. However, in the clinical and
epidemiological settings, current and past infec-
tions of the whole gastric mucosa are typically of
interest. Genotypic methods are then limited by
the availability of biological specimens from
sometimes asymptomatic individuals, and by
the need to assess strain variants dispersed
throughout the stomach. Despite previous advice
against serology [4], the present data support the
application of well-evaluated serological assays in
clinical and epidemiological studies.
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ABSTRACT
This study assessed immunity to poliomyelitis in
a representative sample of 1064 persons living in
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